Loading clinical trials...

Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1/2NCT04539262

Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation

The primary objective of this study is to characterize the impact of inhaled remdesivir (RDV) on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load in participants with early stag...

Lead sponsor: Gilead Sciences•28 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Viral Infections in Healthy and Immunocompromised Hosts

NCT01306084 · Anogenital Herpes, COVID-19, and more

RECRUITING

The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors

NCT04551378 · COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm, and more

RECRUITINGNA

REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19

NCT05218083 · COVID-19, Critical Illness, and more

RECRUITING

Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases

NCT05078905 · COVID-19, Vaccination, and more

RECRUITINGPhase 1

A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir

NCT07552779 · Coronavirus Disease 2019, Coronavirus Disease 2019 (COVID-19), and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 3, 2022Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1/PHASE2

Enrollment156

Start dateSep 2020

Last updatedMar 3, 2022

Condition

COVID-19

Locations shown

The Institute for Liver Health

Mesa, Arizona

The Institute for Liver Health

Tucson, Arizona

Franco Felizarta, MD

Bakersfield, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 3, 2022Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Viral Infections in Healthy and Immunocompromised Hosts

The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors

REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19

Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases

A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir

Trial snapshot

Condition

Locations shown

For caregivers